These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21336713)

  • 1. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
    Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
    Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bevacizumab on radiation necrosis of the brain.
    Gonzalez J; Kumar AJ; Conrad CA; Levin VA
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
    Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
    Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
    Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.
    Narayana A; Golfinos JG; Fischer I; Raza S; Kelly P; Parker E; Knopp EA; Medabalmi P; Zagzag D; Eagan P; Gruber ML
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):383-9. PubMed ID: 18793954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
    Liu AK; Macy ME; Foreman NK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of cerebral radiation necrosis by bevacizumab.
    Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
    J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
    Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation and bevacizumab in high-grade glioma retreatment settings.
    Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
    Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.
    Wang Y; Wang E; Pan L; Dai J; Zhang N; Wang X; Liu X; Mei G; Sheng X
    J Neurooncol; 2014 Sep; 119(2):369-76. PubMed ID: 24879376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
    Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.
    Rusthoven KE; Olsen C; Franklin W; Kleinschmidt-DeMasters BK; Kavanagh BD; Gaspar LE; Lillehei K; Waziri A; Damek DM; Chen C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):211-7. PubMed ID: 20732762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features.
    Zhang W; Lin Y; Chen B; Song SW; Jiang T
    Childs Nerv Syst; 2010 Jan; 26(1):137-43. PubMed ID: 19823845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.